Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-07-22

Clinical Trial Update: Obalon in Children With Severe Obesity [Phase 3]

View source ↗

Summary

A Phase 3 trial of the Obalon gastric balloon in children with severe obesity has completed, with observations including impaired glucose tolerance and altered …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Obalon

Snippet

Sponsor: Bambino Gesù Hospital and Research Institute | Conditions: Severe Pediatric Obesity (BMI > 97° pc -According to Centers for Disease Control and Prevention BMI Charts-), Altered Liver Function Tests | Phase 3 | Status: COMPLETED